Skip to main content
Premium Trial:

Request an Annual Quote

CDC Buys $1M Worth of Advion's NanoMate Instruments for Chemical Terrorism Program

NEW YORK (GenomeWeb News) — The Centers for Disease Control and Prevention will pay $1 million to buy eight of Advion BioSystems’ mass spectrometry-based TriVersa NanoMate units, the firm said today.
 
The systems will be used at Level One state testing sites in the Laboratory Resource Network, the CDC’s national chemical terrorism program.
 
According to Advion, a subsidiary of ADvion BioSciences, the CDC already has three NanoMate units installed in the LRN. The instruments will be used to conduct early response screening for chemical terrorism analyses using chip-based nanoelectrospray mass spectrometry.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more